The U.S. Senate Committee on Health, Education, Labor & Pensions discussed the issue and potential solutions of drug prices. Providing more transparency for patients, lower drug prices, and prohibiting gag clauses were areas of bipartisan agreement. Specific topics discussed were drug rebates, how HHS is handling refugee children, drug negotiations, and drug pricing transparency. Committee Democrats acknowledged that there are ideas in the President’s blueprint that they could agree with.
Full memo can be accessed here.